TIMI 3A

TIMI IIIA evaluated the effect of rtPA vs. placebo on the culprit coronary lesion in patients with unstable angina or non-Q-wave myocardial infarction.

DOWNLOAD SLIDE SET (PDF)

Key Study Publications

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38-52. Abstract